Clinical Features and Long-Term Outcome in Adult Stroke Patient due to Moyamoya Disease : A Single Subject Study

  • Kwon, Yong Hyun (Department of Physical Therapy, Yeungnam College of Science and Technology) ;
  • Kim, Chung Sun (Department of Physical Therapy, College of Rehabilitation Science, Daegu University)
  • Received : 2013.03.31
  • Accepted : 2013.06.10
  • Published : 2013.06.25


This case report described a single case of adult stoke patient due to Moyamoya disease through long-term follow-up observation, which included his demographics, brain images, and change of motor function and functional activities. The subject was the 54-year-old male diagnosed with left hemiparesis from a stroke due to multifocal encephalomalacia in both hemispheres. At the time of the stroke attack, he took brain surgery intervention including external ventricular drain. Physical and occupational therapy for stroke rehabilitation were admitted including muscle strengthening exercises, functional activity/ADL training, neurofacilitative techniques with bobath or proprioceptive neuromuscular facilitation concepts, and compensatory strategy. Patient's MRI showed that right frontal lobe, right peri-ventricular area, left parietal, and left occipital lobes were damaged, and MRA showed that abnormal collateral vessel was richly developed in both hemispheres by occlusion of proximal internal carotid arteries in both sides. His motor strength was improved from poor to good grade in all of upper and lower limb motions, that MBC was improved from stage 1 to stage 5. In FAC and barthel index, at the initial evaluation, he could not perform any functional movement, but his FAC and barthel index were on 3 and 14 points at present, respectively. During long-term follow-up for approximately 4 years, the subject's functional motor ability was improved, as similar with recovery progression of usual stroke patient. We believe that this single case report will provide clinical information and concern regarding Moyamoya disease with physical therapist, in terms of such as epidemiology, pathogenesis, diagnostic procedures, clinical features, recovery process, and prognosis.


  1. Song BK. Effect of somatosensory stimulation on upper limb in sensory, hand function, postural control and adls within sensorimotor deficits after stroke. J Korean Soc Phy Ther. 2012;24(5):291-9.
  2. Lee JS, Nam KW, Kim KY et al. Effect of weight bearing exercise on weight bearing and balance for patients with chronic stroke. J Korean Soc Phy Ther. 2012;24(4):253-61.
  3. Adamson J, Beswick A, Ebrahim S. Is stroke the most common cause of disability? J Stroke Cerebrovasc Dis. 2004;13(4):171-7.
  4. Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. Lancet. 2011;377(9778):1693-702.
  5. Liepert J. [evidence-based methods in motor rehabilitation after stroke]. Fortschr Neurol Psychiatr. 2012;80(7):388-93.
  6. Caplan LR, van Gijn J. Stroke syndrome. Cambridge, UK: Cambridge University Press; 2012.
  7. Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg. 2011;76(6 Suppl):S85-90.
  8. Bogousslavsky J, Caplan LR. Uncommon causes of stroke. Cambridge, UK: Cambridge Univeristy Press; 2001:241-57.
  9. Takahashi JC, Miyamoto S. Moyamoya disease: Recent progress and outlook. Neurol Med Chir (Tokyo). 2010;50(9):824-32.
  10. Smith ER, Scott RM. Moyamoya: Epidemiology, presentation, and diagnosis. Neurosurg Clin N Am. 2010;21(3):543-51.
  11. Takeuchi K, Shimizu K. Hypoplasia of the bilateral carotid arteries. Brain Nerve. 1957;937-43.
  12. Moore DP, Lee MY, Macciocchi SN. Neurorehabilitation outcome in moyamoya disease. Arch Phys Med Rehabil. 1997;78(6):672-5.
  13. Kim SK, Cho BK, Phi JH et al. Pediatric moyamoya disease: An analysis of 410 consecutive cases. Ann Neurol. 2010;68(1):92-101.
  14. Yonekawa Y, Ogata N, Kaku Y et al. Moyamoya disease in europe, past and present status. Clin Neurol Neurosurg. 1997;99 Suppl 2S58-60.
  15. Im SH, Cho CB, Joo WI et al. Prevalence and epidemiological features of moyamoya disease in korea. J Cerebrovasc Endovasc Neurosurg. 2012;14(2):75-8
  16. Dusick JR, Gonzalez NR, Martin NA. Clinical and angiographic outcomes from indirect revascularization surgery for moyamoya disease in adults and children: A review of 63 procedures. Neurosurgery. 2011;68(1):34-43; discussion
  17. Fujimura M, Tominaga T. Lessons learned from moyamoya disease: Outcome of direct/indirect revascularization surgery for 150 affected hemispheres. Neurol Med Chir (Tokyo). 2012;52(5):327-32.
  18. Koss M, Scott RM, Irons MB et al. Moyamoya syndrome associated with neurofibromatosis type 1: Perioperative andlong-term outcome after surgical revascularization. J Neurosurg Pediatr. 2013;11(4):417-25.
  19. Liu X, Zhang D, Shuo W et al. Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease. J Neurol Neurosurg Psychiatry. 2013;84(3):258-65.
  20. Lincoln N, B., Jackson JM, Adams S, A. Reliability and revision of the nottingham sensory assessment for stroke patients. Phsiotherapy. 1998;84(8):358-65.
  21. Kucukdeveci AA, Yavuzer G, Tennant A et al. Adaptation of the modified barthel index for use in physical medicine and rehabilitation in turkey. Scand J Rehabil Med. 2000;32(2):87-92.
  22. Miyamoto S, Kondo T, Suzukamo Y et al. Reliability and validity of the manual function test in patients with stroke. Am J Phys Med Rehabil. 2009;88(3):247-55.
  23. Thieme H, Ritschel C, Zange C. Reliability and validity of the functional gait assessment (german version) in subacute stroke patients. Arch Phys Med Rehabil. 2009;90(9):1565-70.
  24. Bao XY, Duan L, Li DS et al. Clinical features, surgical treatment and long-term outcome in adult patients with moyamoya disease in china. Cerebrovasc Dis. 2012;34(4):305-13.
  25. KIm J, Y., Lee D, H., O YT. Development of brain infarction after extracanial-intracranial bypass surgery in a patient with moyamoya disease - a case report-. Korean J Anesthesilo. 2005;49(3):438-42.
  26. Mukawa M, Nariai T, Matsushima Y et al. Long-term followup of surgically treated juvenile patients with moyamoya disease. J Neurosurg Pediatr. 2012;10(5):451-6.
  27. Phi JH, Wang KC, Cho BK et al. Long-term social outcome in children with moyamoya disease who have reached adulthood. J Neurosurg Pediatr. 2011;8(3):303-9.
  28. Liu W, Hashikata H, Inoue K et al. A rare asian founder polymorphism of raptor may explain the high prevalence of moyamoya disease among east asians and its low prevalence among caucasians. Environ Health Prev Med. 2010;15(2):94-104.